OpenNeedle Ask your own

Question explored with the scientific record

Conversation so far

  1. 1 Is there an epidemic of autoimmune disease in the US
  2. 2 What are the main auto immune diseases and are there tests for all of them

Answered on this page ↓

What are the main auto immune diseases and are there tests for all of them

Nov 22, 2026 · 8 sources used · OpenNeedle synthesis
The short version: there is no single list of "the" autoimmune diseases, and no, there is no reliable test for most of them.

Autoimmune disease is a category, not a diagnosis. The records here cluster on a few: rheumatoid arthritis, celiac disease, type 1 diabetes, lupus, and Sjögren's. For each, the test is a marker, not a verdict. A positive antibody can exist without disease, and a negative one does not rule it out.

For rheumatoid arthritis, the anti-CCP test is specific but misses people: sensitivity 54% with 96% specificity in one early-arthritis study [1], and 67.5% sensitivity with 99.3% specificity in another [3]. Rheumatoid factor is less specific [3]. Genetic markers added nothing beyond the antibodies [2]. For celiac, tTG IgA is the best single test but sensitivity drops in real-world labs, from about 90% in total villous atrophy to 42% in partial [5]. For type 1 diabetes, multiple islet autoantibodies predict progression, but up to 60% of people with a single antibody revert to negative [4]. For lupus, ANA is sensitive but poorly specific: in one uveitis population the positive predictive value was 2.9%, about 34 false positives per true positive [8].

DiseaseBest testKey limitation
Rheumatoid arthritisAnti-CCP2 [1]Misses ~46% in early disease [1]
Celiac diseasetTG IgA [6]Sensitivity falls with milder damage [5]
Type 1 diabetesIslet autoantibodies [4]Single antibody often reverts [4]
LupusANA plus anti-dsDNA [7]ANA has low predictive value [8]

What this retrieval does not contain: multiple sclerosis, thyroid autoimmunity, psoriasis, inflammatory bowel disease, or myasthenia gravis. Those are major autoimmune conditions, and their tests are not represented here. So the honest answer to "are there tests for all of them" is no, and even where tests exist, they are aids to a clinical diagnosis, not proof on their own.

My call: expect a panel of antibody tests plus symptoms and exam, not a single confirming test, and treat any positive result as a question, not an answer. Confidence: moderate.

Keep digging

Sources used 8

  1. A comparison of the diagnostic accuracy and prognostic value of the first and second anti-cyclic citrullinated peptides (CCP1 and CCP2) autoantibody tests for rheumatoid arthritis Thin

    This study compares the diagnostic performance and prognostic value of anti-cyclic citrullinated peptide (CCP1) and anti-CCP2 autoantibody tests in patients with early arthritis, finding that the CCP2 test is superior in both aspects.

    DOI: 10.1136/ard.2004.035089
  2. Contribution of PTPN22 1858T, TNFRII 196R and HLA-shared epitope alleles with rheumatoid factor and anti-citrullinated protein antibodies to very early rheumatoid arthritis diagnosis Rheumatology (2008) Thin

    This study evaluates the predictive value of genetic markers PTPN22 1858T, TNFRII 196R, and HLA-shared epitope alleles in conjunction with rheumatoid factor and anti-citrullinated protein antibodies for diagnosing rheumatoid arthritis in patients with very early arthritis, findi…

    DOI: 10.1093/rheumatology/ken192
  3. Proteomic: New advances in the diagnosis of rheumatoid arthritis Clinica Chimica Acta (2005) Thin

    This study evaluates the diagnostic and prognostic potential of anti-cyclic citrullinated peptide (anti-CCP) antibodies in rheumatoid arthritis, highlighting their effectiveness as serological markers compared to traditional rheumatoid factor tests.

    DOI: 10.1016/j.cccn.2005.03.030
  4. Early prediction of autoimmune (type 1) diabetes Diabetologia (2017) narrative review Strong

    HLA genetic variation is the major determinant of birth risk for type 1 diabetes, and the appearance of multiple islet autoantibodies strongly predicts progression to clinical diabetes, supporting a three-stage progression model.

    DOI: 10.1007/s00125-017-4308-1
  5. Utility in Clinical Practice of Immunoglobulin A Anti-Tissue Transglutaminase Antibody for the Diagnosis of Celiac Disease Clinical Gastroenterology and Hepatology (2006) Thin

    This study evaluates the sensitivity and specificity of the anti-tissue transglutaminase antibody test for diagnosing celiac disease in clinical practice, revealing lower sensitivity compared to research settings and significant variability among commercial laboratories.

    DOI: 10.1016/j.cgh.2006.02.010
  6. Serological testing for celiac disease in adults United European Gastroenterology Journal (2013) systematic review Strong

    In adults, tTG IgA and DGP IgG showed the best single-assay performance for celiac disease, but evidence was insufficient to recommend diagnosis without biopsy.

    DOI: 10.1177/2050640613502788
  7. When to order an antinuclear antibody test BMJ (2013) Thin

    This study discusses the diagnostic steps and tests necessary for identifying autoimmune rheumatic diseases, particularly focusing on the antinuclear antibody test and its implications in diagnosing systemic lupus erythematosus (SLE).

    DOI: 10.1136/bmj.f5060
  8. Association of Systemic Lupus Erythematosus With Uveitis JAMA Ophthalmology (2015) Thin

    Systemic lupus erythematosus is a rare cause of uveitis, and routine ANA testing has a low positive predictive value, based on a global literature review (63 studies, 53,315 patients) showing a prevalence of 0.47%.

    DOI: 10.1001/jamaophthalmol.2015.2249

Your question next

What do you want to know?

No question is too uncomfortable for the evidence. Bring yours.

Ask your question →